Skip to main content

Home/ MaRS/ Group items tagged Commercialization

Rss Feed Group items tagged

Assunta Krehl

Ontario Institute for Cancer Research Plans Hires, Increased Commercial Activities - Ge... - 0 views

  •  
    The Ontario Institute for Cancer Research in 2010 will grow its workforce, step up efforts to commercialize discoveries, and aim to fulfill research goals to be detailed in a second strategic plan set to be submitted next month to provincial officials, according to the institute's president and scientific director, Tom Hudson.
Assunta Krehl

The Centre for Commercialization of Regenerative Medicine (CCRM): CCRM Announces Its In... - 0 views

  •  
    Rafi Hofstein, President and CEO of MaRS Innovation is one of the inaugural Board of Directors for The Centre for Commercialization of Regenerative Medicine (CCRM). CCRM is a MaRS tenant.
Sarah Hickman

U.S. Commercial Service : Your Global Business Partner - 0 views

  •  
    The US Commercial Service provides an excellent and free-for-use International Market Research search tool for 18 global industries. Global market research reports, country commercial guides, and best market reports can be accessed via search by industry, sector, region, country, keyword, or type of report. Older archived records can also be retrieved. The site offers search tips for finding market reports, as well as e-alerts.
Assunta Krehl

Canada must fight its addiction to the old economy - The Globe and Mail - July 5, 2012 - 1 views

  •  
    Dezso J. Horvath is Tanna H. Schulich Chair in Strategic Management and dean of the Schulich School of Business at York University in Toronto and Matthias Kipping is a professor of policy and chair in business history at Schulich state " Canadian businesses to wean themselves off traditional industries and tried-and-true markets, to instead develop - and commercialize - innovative technology." MaRS Discovery District is bridging the commercialization gap.
Assunta Krehl

Time to build the Toronto of Tomorrow - The Star - 0 views

shared by Assunta Krehl on 27 Aug 09 - Cached
  • Other successes of the past year include the creation of the MaRS Discovery District, a new centre on University Ave. that focuses on commercializing biomedical research, and the Toronto Waterfront Revitalization Corp., he said
  •  
    According the Toronto Star, Dale Richmond states that he "believes it is a perfect time to lobby Ottawa and Queen's Park for Toronto's needs. Successes of the past include the MaRS project that focuses on commercializing biomedical research."
  •  
    According the Toronto Star, Dale Richmond states that he believe it is a perfect time to lobby Ottawa and Queen's Park for Toronto's needs. Successes of the past include the MaRS project that focuses on commercializing biomedical research. Jan 23, 2003
Sarah Hickman

Commercialization Portal - Home - 0 views

  •  
    Great Industry Canada source for Innovation, Research, and Science and Technology commercialization. Links to Information Resources, Diagnostic Tools, Industry Associations, Financing, laws, and other services are provided.
Assunta Krehl

Look who just landed on MaRS - The Globe and Mail - 0 views

  • Look who just landed on MaRS
  • MaRS was known for just that – putting a collective roof over the heads of Canada's out-of-this-universe thinkers. Aside from hosting the unlikely duo of Arnold Schwarzenegger and Dalton McGuinty at a funding announcement two years ago, the centre seems enveloped in galactic silence.
  • corner of College and University
  • ...12 more annotations...
  • the country's most significant collection of scientific and medical researchers.
  • This week, a program called MaRS Innovation announced the appointment of its first full-time president, Raphael (Rafi) Hofstein, a Harvard-trained, Israeli biomedical wizard who wants to bring together companies, scientists and funding under one roof to create a special alchemy of science and shekels.
  • Since its inception, MaRS has focused on turning big ideas into commercial projects. The difference between the two entities is that pretty much anyone with an idea or discovery could come to MaRS for support, regardless of whether they had their “eureka” moment in a state-of-the-art research lab or in their garage. MaRS Innovation, a separate endeavour with its own board of directors, only works with researchers from its 14 partner institutions, which include some of the most prestigious universities and hospitals in Canada. The goal of that project is to do the kind of work those institutions would normally try to do in-house, but on a bigger scale and, the project's backers hope, with better results.
  • MaRS Innovation is very much in its infancy. Officially launched last June, the project is barely a year old, and the board of directors was only announced this February. It has secured about $25-million in funding over five years to be used for commercialization of projects.
  • Dr. Hofstein is giving himself two to three years to roll out a success story – be it the creation of a new small company founded on the back of a researcher's drug discovery and funded by a big pharmaceutical firm, or a new discovery that, packaged properly, attracts serious venture-capital money.
  • The federal government has also taken notice, naming MaRS Innovation as one of 11 new “Centres of Excellence for Commercialization and Research,” a designation that came with almost $15-million in funding.
  • California Governor Arnold Schwarzenegger speaks at MaRs with Premier Dalton McGuinty after a tour of the building in 2007.
  • Indeed, the MaRS Innovation model of pushing for commercial applications of research seems to be directly in line with the philosophy of the Conservative government, which clearly favours practical results when it comes to funding for scientific research.
  • But those tasks involve two separate skill sets, Mr. Tabrizi suggests, and may be much better suited to a place such as MaRS, where academic and industry heavyweights converge.
  • Many of MaRS's biggest partners are in health care, and Dr. Hofstein is jumping in with a list of priorities that includes focusing on stem-cell research and oncology.
  • MaRS itself has always been good at bringing people from various sectors together, but there's no guarantee that Dr. Hofstein's plan will work, especially in the two-to-three-year timeline he mentions when talking about a rollout date for the first MaRS Innovation projects.
  • Indeed, Mr. Tabrizi says some Silicon Valley insiders marvel at what MaRS Innovation is trying to do. “I think there's something innovative there,” he says. “Something different is being done.”
  •  
    MaRS Innovation announced the appointment of its first full-time president, Raphael (Rafi) Hofstein.
Assunta Krehl

Homegrown products may help extend lives - Guelph Mercury - 0 views

  • It is clear humans will live much longer in the future, Worzel says. And innovative agricultural products, like those being developed by University of Guelph research scientists, will play a vital role in maintaining the health of this future population of senior citizens.
  • Worzel was a keynote speaker at last week's Agri-Food Innovation Forum in Toronto, which brought leading scientists, medical professionals, government and industry officials together to explore the future of so-called functional foods and nutraceuticals -- foods or food extracts that have physiological benefits or reduce the risk of chronic disease.
  • Guelph scientists are among the world leaders in the field, with a host of University of Guelph researchers advancing the science, and a number of local enterprises -- Soy 20/20, BioEnterprise, Ontario Agri-Food Technologies, and MaRS Landing -- working to commercialize that science.
  •  
    Contemporary geneticists believe it might be possible to alter human DNA in a way that would allow people to live extremely long lives. Mention of Guelph scientists hosted of the University of Guelph, Ontario Agri-Food Technologies, and MaRS Landing in advancing research and commercializing that science.
  •  
    Contemporary geneticists believe it might be possible to alter human DNA in a way that would allow people to live extremely long lives. Mention of Guelph scientists hosted at the University of Guelph, Ontario Agri-Food Technologies, and MaRS Landing in advancing research and commercializing that science. Feb 18, 2009
Assunta Krehl

YFile - Symposium examines the path to breakthrough medicines - 0 views

  • Canada has the research expertise to develop drugs and vaccines to address pressing medical needs, but delivering on the promise will require new models of collaboration between scientists, biotechnology, the pharmaceutical industry, business and policy makers according to speakers at an upcoming symposium hosted by The Gairdner Foundation and York University. The symposium, Entrepreneurship & Commercialization in Biomedical Science, on Thursday, May 14, marks the 50th anniversary of both York University and The Gairdner Foundation.
  • The Gairdner Foundation recognizes the world's leading medical research scientists through its prestigious annual awards program for biomedical science. The symposium, which is hosted by York’s Faculty of Science & Engineering and Schulich School of Business, will bring together scientist entrepreneurs, Canadian venture capital firms, the biomedical industry and policy-makers.
  • He will be followed by Smith, founder and former president & CEO of RBC Ventures and a member of the board of Toronto's MaRS innovation centre. Smith will speak about how Canada has made strong progress in positioning itself as a potential leader in biotech and medical research and in its commercialization efforts but faces two clear threats – the global financial calamity together with the lack of clear federal government support for research.
  •  
    The symposium, Entrepreneurship & Commercialization in Biomedical Science, is being held on Thursday, May 14, which marks the 50th anniversary of both York University and The Gairdner Foundation. At this symposiums they will address the problem that Canadian researchers expertise to need to do in developing drugs and vaccines to address pressing medical needs. Mention of Susan Smith as a Board Member of MaRS Innovation.
Sarah Hickman

O C E T A - Partnering for a Sustainable Future - 0 views

  •  
    OCETA accelerates the commercialization and market adoption of clean technologies and environmentally sustainable solutions. OCETA provides technical and business services to support technology entrepreneurs and start-up companies with commercializing and bringing their innovations to market. These services include: * Business mentoring and coaching: Strengthening management capability, strategic planning, route to market, IP strategy and protection. * Business networks: Connecting entrepreneurs to networks of established peers, mentors and experts. * Technology: Providing 3rd party assessment, demonstration, verification, scale-up and deployment. * Financing: Finding access to capital and improving investment readiness. * Marketing: Assisting in market niche identification and segmentation and export assistance.
George Botos

IP Osgoode Event: Entrepreneurship, Innovation and Commercialization of Intellectual Pr... - 0 views

  •  
    Entrepreneurship, Innovation and Commercialization of Intellectual Property
Assunta Krehl

Canadian Space Commerce Association Meeting to Highlight Growing Canadian Commercial Sp... - 0 views

  •  
    The Canadian Space Commerce Association will be holding its annual meeting in Toronto on Tuesday, March 16th with the theme "The Growing Canadian Commercial Space Sector" at the MaRS Centre.
Assunta Krehl

Medical lab operator CML HealthCare outlines strategy for growth, innovation - 680News ... - 0 views

  •  
    CML HealthCare Inc is planning to automate it's current infrastructure to deliver greater volume and medical laboratory tests. CML is also working to commercialize early-stage technologies in medical diagnostics in partnership with an Ontario government agency known as MaRS Innovation.
Assunta Krehl

Cure may be right under our noses - Star Business Club - May 27, 2012 - 1 views

  •  
    CHALLENGE: It's got potential and is ready to be built, but is the science sound? And can a fringe medical treatment have mass appeal?
  •  
    Lew Lim founder of Mediclights is a MaRS client and is bringing intranasal light therapy to Canada. Peter Adams, a MaRS Life Science and Healthcare IT advisor is working with Lim to commercializing this innovation. They would like to see Toronto as the new hub for interanasal laser research.
Assunta Krehl

Microfluidic device designed for large-scale tissue engineering - Gizmag - August 2, 2012 - 0 views

  •  
    According to Ben Coxworth, reporter, at Gizmag states the University of Toronto has developed a "microfluidic device ... that can reportedly produce sections of precisely-engineered tissue that measure within the centimeters. This innovation is currently being commercialized by MaRS Innovation.
Assunta Krehl

Tridel uses Internet Protocol to improve building security, energy efficiency - Daily C... - 0 views

  •  
    Greg Meckback, Digital Media Editor from Daily Commercial News states "Toronto real estate developer Tridel is partnering with Cisco Systems Inc. to use Internet Protocol (IP) technology to improve energy efficiency, security and entertainment systems in its buildings....TowerLabs with Tridel co-founded with the MaRS Discovery District, is getting feedback from focus groups on devices such as programmable thermostats or the possibility of putting programmable thermostat functions on a portable electronic device such as Apple Inc.'s iPhone."
Assunta Krehl

Making Clean Tech a Commercial Reality, Faster - Triple Pundit - January 25, 2012 - 0 views

  •  
    Jonathan Dogterom, MaRS Cleantech Advisor suggests, MaRS "puts an incubation and collaboration center on steroids." The convergence center helps to bring business and entrepreneurs to innovate and bring commercialize these ideas faster.
Assunta Krehl

John Evans family donates $10-million to MaRS - The Globe and Mail - February 23, 2012 - 1 views

  •  
    The family of Dr. John Evans, an innovator in both medicine and business, is donating $10-million to the Toronto MaRS Discovery District. The money will be used to create a MaRS Solutions Lab, which will be designed to help tackle a range of problems - from the commercialization of medical discoveries to global health issues - while providing opportunities for young Canadians, who will have the chance to become fellows at MaRS.
Assunta Krehl

On the Up - The Scientist - June 14, 2010 - 0 views

  •  
    Ontario is known for its groundbreaking science and it now starting to recognition for biotech. MaRS Discovery District is a nonprofit corporation founded in 2000 to help commercialize Ontario's research.
‹ Previous 21 - 40 of 150 Next › Last »
Showing 20 items per page